EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer. (20th August 2020)

• Record Type: Journal Article
• Authors: Wakae, Kousho; Kondo, Satoru; Pham, Hai Thanh; Wakisaka, Naohiro; Que, Lusheng; Li, Yingfang; Zheng, Xin; Fukano, Kento; Kitamura, Kouichi; Watashi, Koichi; Aizaki, Hideki; Ueno, Takayoshi; Moriyama‐Kita, Makiko; Ishikawa, Kazuya; Nakanishi, Yosuke; Endo, Kazuhira; Muramatsu, Masamichi; Yoshizaki, Tomokazu
• Is Part Of: Cancer medicine. Volume 9:Number 20(2020)
• Page Start: 7663
• Page End: 7671
• Publication Date: 2020-08-20
• Subjects: APOBEC -- EBV‐LMP1 -- mitochondrial DNA -- nasopharyngeal cancer; 616.994005
• DOI: 10.1002/cam4.3357
• Languages: English
• ISSNs: 2045-7634

Abstract

Abstract: An Epstein‐Barr virus (EBV)—encoded latent membrane protein 1 (LMP1) is a principal oncogene that plays a pivotal role in EBV‐associated malignant tumors including nasopharyngeal cancer (NPC). Recent genomic landscape studies revealed that NPC also contained many genomic mutations, suggesting the role of LMP1 as a driver gene for the induction of these genomic mutations. Nonetheless, its exact mechanism has not been investigated. In this study, we report that LMP1 alters the expression profile of APOBEC3s(A3s), host deaminases that introduce consecutive C‐to‐U mutations (hypermutation). In vitro, LMP1 induces APOBEC3B (A3B) and 3F(A3F), in a nasopharyngeal cell line, AdAH. Overexpression of LMP1, A3B, or A3F induces mtDNA hypermutation, which is also detectable from NPC specimens. Expression of LMP1 and A3B in NPC was correlated with neck metastasis. These results provide evidence as to which LMP1 induces A3s and mtDNA hypermutation, and how LMP1 facilitates metastasis is also discussed. Abstract : EBV LMP1 induces host cytidine deaminases, APOBECs, in nasopharyngeal cells. TES2 domain is important for LMP1‐induced LMP1 hypermutates host mitochondrial genome.